Healthcare -
Biotechnology - NASDAQ - US
$ 0.6581
-0.903 %
$ 83 M
Market Cap
-0.63
P/E
KPTI - OPERATING EXPENSES
Operating Expenses KPTI - Karyopharm Therapeutics Inc.
271 M
LAST VALUE
-5.75%
2 YEAR CAGR
5.18%
5 YEAR CAGR
22.93%
10 YEAR CAGR